<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04105647</url>
  </required_header>
  <id_info>
    <org_study_id>UW19-597-2</org_study_id>
    <nct_id>NCT04105647</nct_id>
  </id_info>
  <brief_title>Lifestyle Modification Program for Lung Cancer Patients - A Pilot Study</brief_title>
  <official_title>A Brief Messaging Lifestyle Modification Program for Patients With Non-small Cell Lung Cancer - A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Hong Kong</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lung cancer is one of the most common cancer diseases, globally and locally. Several health
      benefits of increased physical activity (PA) have been reported for people with cancer. PA
      plays a critical role across the cancer trajectory, from prevention through to post-diagnosis
      and has been proposed as an alternative for improving physical and psychosocial health
      outcomes, reducing cancer recurrence, and cancer-specific and all-cause mortality.

      Although there are a variety of exercise intervention programs for cancer patients, those
      programs were quite intensive, requiring individuals to commit extra time and effort. Feeling
      of overwhelmed appointments, lack of time, other barriers, including high cost and limited
      access to facilities are the most frequently reported barriers that prevent people from
      starting and maintaining exercise. Hence, the investigators propose to use a brief messaging
      lifestyle modification intervention program to incorporating simple and easy-to-do
      patient-centred home-based lifestyle-integrated exercise into daily activities of patients
      with lung cancer. The aims are to increase patients' physical activity and improve their
      fatigue, emotion and quality of life, compared to the control group.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Lung cancer is one of the most common cancer, globally and locally. Patients with lung cancer
      are in a uniquely challenging situation in their disease, comorbidities, and treatment that
      may lead to worsened symptoms and many negative health consequences, including fatigue,
      irritability, and impaired daytime functioning.

      Physical activity (PA) is defined as 'any bodily movement produced by skeletal muscle that
      results in energy expenditure'. Several health benefits of increased PA have been reported
      for people with cancer. PA plays a critical role across the cancer trajectory, from
      prevention through to post-diagnosis and has been proposed as an alternative for improving
      physical and psychosocial health outcomes, reducing cancer recurrence, and cancer-specific
      and all-cause mortality. Although there are a variety of exercise intervention programs for
      cancer patients, those programs were quite intensive, requiring individuals to commit extra
      time and effort. Most clinicians underutilise exercise therapy, regardless of its low-cost
      way to improve symptoms and potential health outcomes. Feeling of overwhelmed appointments,
      lack of time, other barriers, including high cost and limited access to facilities are the
      most frequently reported barriers that prevent people from starting and maintaining exercise.
      Low motivation, fear to exercise, lack of knowledge about benefits are the most common
      barriers of engaging in physical activity for cancer patients.

      Hence, the current proposal is to use a brief messaging lifestyle modification intervention
      program to incorporating simple and easy-to-do patient-centred home-based
      lifestyle-integrated exercise (light to moderate physical activity) into daily activities of
      patients with lung cancer.

      The investigators hypothesised that patients in the experimental group would display
      significantly higher increases in physical activity and improvements in fatigue, emotion and
      quality of life, compared to the control group.

      The objectives are to examine the short-term clinical effects on impacts on fatigue, emotion
      and quality of life in patients with lung cancer, and to evaluate the feasibility of a brief
      lifestyle-integrated exercise program to increase physical activity by a pilot study with
      objective fitness and subjective questionnaire assessment, and focus group interviews.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2019</start_date>
  <completion_date type="Anticipated">May 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The control group will receive a face-to-face group session and a package of instant messages related to healthy living information, but no information on lifestyle-integrated exercise and physical activity.
The experimental group will receive a face-to-face group session and a package of information on lifestyle-integrated exercise and physical activity.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in fatigue level at 6 weeks</measure>
    <time_frame>Baseline and 6 weeks</time_frame>
    <description>measured by Brief Fatigue Inventory</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in physical activity at 6 weeks</measure>
    <time_frame>Baseline and 6 weeks</time_frame>
    <description>measured by International Physical Assessment Questionnaire - Short version</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in health-related quality of life at 6 weeks</measure>
    <time_frame>Baseline and 6 weeks</time_frame>
    <description>measured by European Organisation for Research and Treatment of Cancer and lung module questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in functional level at 6 weeks</measure>
    <time_frame>Baseline and 6 weeks</time_frame>
    <description>measured by Functional Assessment Cancer Therapy - Lung (FACT-L) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in anxiety and depression symptoms at 6 weeks</measure>
    <time_frame>Baseline and 6 weeks</time_frame>
    <description>measured by Hospital Anxiety and Depression Scale. Each item is answered on a 4-point scale (0-3). The scores for the seven questions on depression are added together to obtain a score ranged from 0 to 21. The higher score the more depressed. The scores for the seven questions on anxiety are added together to obtain a score ranged from 0 to 21. The higher score the more anxiety.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in insomnia level at 6 weeks</measure>
    <time_frame>Baseline and 6 weeks</time_frame>
    <description>measured by Insomnia Severity Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in sleep quality at 6 weeks</measure>
    <time_frame>Baseline and 6 weeks</time_frame>
    <description>measured by Pittsburgh Sleep Quality Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in excessive daytime sleepiness at 6 weeks</measure>
    <time_frame>Baseline and 6 weeks</time_frame>
    <description>measured by Epworth Sleepiness Scale. It is a scale of increasing probability from 0 to 3 for eight different situations that most people engage in during their daily lives, though not necessarily every day. The scores for the eight questions are added together to obtain a score ranged from 0 to 24. The higher score the more sleepiness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in activity level at 6 weeks</measure>
    <time_frame>Baseline and 6 weeks</time_frame>
    <description>measured by fitbits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in hand grips strength at 6 weeks</measure>
    <time_frame>Baseline and 6 weeks</time_frame>
    <description>measured by a dynamometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in lower limb strength at 6 weeks</measure>
    <time_frame>Baseline and 6 weeks</time_frame>
    <description>assessed by using a 30-second chair stand test to record the number of stands from chair in 30 seconds</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in balance at 6 weeks</measure>
    <time_frame>Baseline and 6 weeks</time_frame>
    <description>assessed by a single-leg-stance test by recording the time within which the individual could effectively achieve balance on one leg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in flexibility at 6 weeks</measure>
    <time_frame>Baseline and 6 weeks</time_frame>
    <description>assessed by chair sit and reach test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in endurance at 6 weeks</measure>
    <time_frame>Baseline and 6 weeks</time_frame>
    <description>assessed by 6-minute walk</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Cancer, Lung</condition>
  <arm_group>
    <arm_group_label>Experimental group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in the experimental group will receive a face-to-face group session and a package of healthy lifestyle instant messages, including lifestyle-integrated exercise and physical activity.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The control group will receive a face-to-face group session and a package of healthy lifestyle instant messages, but not related to lifestyle-integrated exercise and physical activity.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Lifestyle-integrated exercise</intervention_name>
    <description>The experimental group will receive a face-to-face group session and a package of instant messages related to lifestyle-integrated exercise and physical activity. The lifestyle-integrated exercise is modified from Zero-time exercise. It focuses on four exercise domains that patients with lung cancer could be done at home, including breathing, balance, aerobic, strength, stretching exercises</description>
    <arm_group_label>Experimental group</arm_group_label>
    <other_name>Experimental group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Healthy living information</intervention_name>
    <description>The control group will receive a face-to-face group session and a package healthy living instant messages, but not related to lifestyle-integrated exercise and physical activity.</description>
    <arm_group_label>Control group</arm_group_label>
    <other_name>Control group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 18 years and above;

          -  Diagnosis with non-small cell lung cancer

          -  General condition stable, either is undergoing or finished treatment

          -  Able to speak and read Chinese

          -  Able to complete the self-administered questionnaire

          -  Able to use instant messages such as WhatsApp or WeChat

          -  Mental, cognitive and physically fit determined by the clinicians/investigators

          -  Signed informed consent

        Exclusion Criteria:

          -  Pre-operative lung cancer

          -  Skeletal fragility

          -  Serious active infection

          -  Inability to walk

          -  Previously untreated symptomatic brain metastases

          -  Severe respiratory insufficiency

          -  Uncontrolled pain
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Agnes Lai</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Hong Kong</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>LAI Agnes, PhD</last_name>
    <phone>852-3917-6328</phone>
    <email>agneslai@hku.hk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mary Ip, MD</last_name>
    <phone>852-2255-4455</phone>
    <email>msmip@hku.hk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Agnes</name>
      <address>
        <city>Hong Kong</city>
        <zip>852</zip>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Agnes YK Lai</last_name>
      <email>agneslai@hku.hk</email>
    </contact>
    <investigator>
      <last_name>Agnes YK Lai, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Queen Mary Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Agnes YK Lai, PhD</last_name>
      <phone>852-3917-6328</phone>
      <email>agneslai@hku.hk</email>
    </contact>
    <contact_backup>
      <last_name>Mary MS Ip, MD</last_name>
      <phone>852-2255-4455</phone>
      <email>msmip@hku.hk</email>
    </contact_backup>
    <investigator>
      <last_name>Agnes YK Lai, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <link>
    <url>https://www.lung.org/lung-health-and-diseases/lung-disease-lookup/lung-cancer/resource-library/lung-cancer-fact-sheet.html</url>
    <description>American Lung Association - Lung Cancer</description>
  </link>
  <reference>
    <citation>Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep. 1985 Mar-Apr;100(2):126-31.</citation>
    <PMID>3920711</PMID>
  </reference>
  <reference>
    <citation>Peddle-McIntyre CJ, Singh F, Thomas R, Newton RU, Galv√£o DA, Cavalheri V. Exercise training for advanced lung cancer. Cochrane Database Syst Rev. 2019 Feb 11;2:CD012685. doi: 10.1002/14651858.CD012685.pub2.</citation>
    <PMID>30741408</PMID>
  </reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>September 24, 2019</study_first_submitted>
  <study_first_submitted_qc>September 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 26, 2019</study_first_posted>
  <last_update_submitted>April 25, 2020</last_update_submitted>
  <last_update_submitted_qc>April 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Dr. Agnes Yuen-Kwan Lai</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Lifestyle modification</keyword>
  <keyword>physical activity</keyword>
  <keyword>messages</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The patient consent did not include sharing personal information to other researchers</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

